ZIKV-IN-1

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

ZIKV-IN-1 

ZIKV-IN-1 是一种有效的 zika virus 抑制剂，EC50 为 2.8 µM，EC90 为 6.8 µM。ZIKV-IN-1 显示出抗 ZIKV 活性，且具有低细胞毒性。ZIKV-IN-1 对 ZIKV RdRp 结构域具有很强的亲和力。

ZIKV-IN-1

ZIKV-IN-1 Chemical Structure

CAS No. : 2762166-06-1

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

ZIKV-IN-1 is a potent zika virus inhibitor with an EC50 of 2.8 µM and EC90 of 6.8 µM. ZIKV-IN-1 shows anti-ZIKV activity with low cytotoxicity. ZIKV-IN-1 shows a strong affinity to ZIKV RdRp domain[1].

IC50 & Target

EC50: 2.8 µM (ZIKV)[1]
体外研究
(In Vitro)

ZIKV-IN-1 (compound 38) (0-80 µM) shows anti-ZIKV activity in a dose-dependent manner in A549 cells[1].
ZIKV-IN-1 (5, 10, 25 µM; 48 h) decreases the expression of ZIKV E and cleaved caspase 3 protein[1].
ZIKV-IN-1 (1.25, 2.5, 5, 10, 20 µM; 0-250 s) shows strong affinity to ZIKV RdRp domain (Kd=1.87 µM) in A549 cells[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: A549 cells
Concentration: 0-50 µM
Incubation Time:
Result: Showed anti-ZIKV activity with an EC50 of 2.8 µM, EC90 of 6.8 µM, and CC50 of >50 µM.

Western Blot Analysis[1]

Cell Line: A549, Vero cells
Concentration: 5, 10, 25 µM
Incubation Time: 48 h
Result: Decreased the expression of ZIKV E and cleaved caspase 3 protein.

Cell Cytotoxicity Assay[1]

Cell Line: Vero, SNB19, Huh7, A549 cells
Concentration: 0-80 µM
Incubation Time:
Result: Showed low cytotoxicity with CC50s of 46.8, 49.4, 43.8, 54.1 µM for ZG01 strain of Vero, SNB19, Huh7, A549 cells, and CC50s of 470.5, 485.2, 512.8, 160.8 µM for MR766 strain of Vero, SNB19, Huh7, A549 cells, respectively.

分子量

478.29

Formula

C21H18BrF2N3O3
CAS 号

2762166-06-1
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Yao G, et al. Design, synthesis, and biological evaluation of novel 2′-methyl-2′-fluoro-6-methyl-7-alkynyl-7-deazapurine nucleoside analogs as anti-Zika virus agents. Eur J Med Chem. 2022 Apr 15;234:114275.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

发表回复